What is the share price of iSERA Lifesciences Ltd (ISERA) today?
The share price of ISERA as on 24th July 2026 is ₹143.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on iSERA Lifesciences Ltd (ISERA) share?
The past returns of iSERA Lifesciences Ltd (ISERA) share are- Past 1 week: N/A%
- Past 1 month: 18.21%
- Past 3 months: 90.24%
- Past 6 months: 507.94%
- Past 1 year: 4468.25%
- Past 3 years: 9824.14%
- Past 5 years: 21377.61%
What are the peers or stocks similar to iSERA Lifesciences Ltd (ISERA)?
The peers or stocks similar to iSERA Lifesciences Ltd (ISERA) include:What is the market cap of iSERA Lifesciences Ltd (ISERA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of iSERA Lifesciences Ltd (ISERA) is ₹121.01 Cr as of 24th July 2026.What is the 52 week high and low of iSERA Lifesciences Ltd (ISERA) share?
The 52-week high of iSERA Lifesciences Ltd (ISERA) is ₹143.90 and the 52-week low is ₹3.15.What is the PE and PB ratio of iSERA Lifesciences Ltd (ISERA) stock?
The P/E (price-to-earnings) ratio of iSERA Lifesciences Ltd (ISERA) is 465.40. The P/B (price-to-book) ratio is -1210.05.Which sector does iSERA Lifesciences Ltd (ISERA) belong to?
iSERA Lifesciences Ltd (ISERA) belongs to the Information Technology sector & Software Services sub-sector.How to buy iSERA Lifesciences Ltd (ISERA) shares?
You can directly buy iSERA Lifesciences Ltd (ISERA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
iSERA Lifesciences Ltd
ISERA Share Price
BSEISERA Stock Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ISERA Performance & Key Metrics
ISERA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 465.40 | -1,210.05 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 21.38 | 5.55 | 3.30% |
ISERA Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
ISERA Company Profile
iSERA Lifesciences Limited is an Indian company engaged in Information Technology and IT Enabled Services.
ISERA Forecast
ISERA Forecasts
ISERA
ISERA
Income
Balance Sheet
Cash Flow
ISERA Income Statement
ISERA Income Statement
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.00 | 0.01 | 0.20 | 1.22 | ||||||||||
| Operating & Other expenses | 0.01 | 0.07 | 0.01 | 0.01 | 0.07 | 0.04 | 0.02 | 0.00 | 0.48 | 0.59 | ||||||||||
| EBITDA | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | 0.23 | -0.02 | 0.01 | -0.28 | 0.63 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | 0.23 | -0.02 | 0.01 | -0.28 | 0.63 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | 0.23 | -0.02 | 0.01 | -0.28 | 0.63 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | ||||||||||
| Net Income | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | 0.23 | -0.02 | 0.01 | -0.28 | 0.55 | ||||||||||
| EPS | -0.35 | -2.04 | -0.35 | -0.38 | -2.06 | 7.13 | -0.05 | 0.28 | -0.34 | 1.58 |
ISERA Company Updates
ISERA Stock Peers
ISERA Past Performance & Peer Comparison
ISERA Past Performance & Peer Comparison
Information TechnologySoftware Services
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| iSERA Lifesciences Ltd | 465.40 | -1,210.05 | — |
| Oracle Financial Services Software Ltd | 35.14 | 11.85 | 3.75% |
| Persistent Systems Ltd | 43.69 | 10.40 | 0.77% |
| L&T Technology Services Ltd | 28.34 | 5.58 | 1.69% |
ISERA Stock Price Comparison
Compare ISERA with any stock or ETFISERA Holdings
ISERA Shareholdings
ISERA Promoter Holdings Trend
ISERA Promoter Holdings Trend
In last 6 months, promoter holding in the company has increased by 55.06%
Pledged promoter holdings is insignificant
ISERA Institutional Holdings Trend
ISERA Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
ISERA Shareholding Pattern
ISERA Shareholding Pattern
ISERA Shareholding History
ISERA Shareholding History
smallcases containing ISERA stock
smallcases containing ISERA stock
Looks like this stock is not in any smallcase yet.
ISERA Events
ISERA Events
ISERA Dividend Trend
ISERA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
ISERA Dividend Trend
ISERA has not given any dividends in last 5 years
ISERA Dividends
ISERA Dividends
ISERA Stock News & Opinions
ISERA Stock News & Opinions
Net profit of Covidh Technologies rose 139.13% to Rs 0.55 crore in the quarter ended March 2026 as against Rs 0.23 crore during the previous quarter ended March 2025. Sales reported to Rs 1.16 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025. For the full year,net profit rose 116.67% to Rs 0.26 crore in the year ended March 2026 as against Rs 0.12 crore during the previous year ended March 2025. Sales reported to Rs 1.36 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1.160 0 1.360 0 OPM %49.140 -19.850 - PBDT0.630.23 174 0.340.14 143 PBT0.630.23 174 0.340.14 143 NP0.550.23 139 0.260.12 117 Powered by Capital Market - Live
Covidh Technologies will hold a meeting of the Board of Directors of the Company on 21 May 2026.
Covidh Technologies will hold a meeting of the Board of Directors of the Company on 20 April 2026.
Covidh Technologies announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 April 2026.Powered by Capital Market - Live
Net Loss of Covidh Technologies reported to Rs 0.28 crore in the quarter ended December 2025 as against net loss of Rs 0.07 crore during the previous quarter ended December 2024. Sales reported to Rs 0.19 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.190 0 OPM %-147.370 - PBDT-0.28-0.07 -300 PBT-0.28-0.07 -300 NP-0.28-0.07 -300 Powered by Capital Market - Live
Covidh Technologies will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live
Net profit of Covidh Technologies reported to Rs 0.01 crore in the quarter ended September 2025 as against net loss of Rs 0.01 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.Powered by Capital Market - Live
Covidh Technologies will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
Covidh Technologies will hold a meeting of the Board of Directors of the Company on 9 October 2025.Powered by Capital Market - Live
Covidh Technologies will hold a meeting of the Board of Directors of the Company on 3 October 2025.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -7.66%, vs industry avg of 15.76%
Over the last 5 years, market share decreased from 0.01% to 0%
Over the last 5 years, net income has grown at a yearly rate of -31.94%, vs industry avg of 13.88%